Thomas Stephan
Stock Analyst at Stifel
(1.83)
# 3,058
Out of 4,854 analysts
44
Total ratings
37.93%
Success rate
-9.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
GKOS Glaukos | Maintains: Buy | $140 → $115 | $93.55 | +22.93% | 9 | May 1, 2025 | |
RXST RxSight | Maintains: Hold | $33 → $28 | $15.24 | +83.73% | 10 | Mar 19, 2025 | |
SGHT Sight Sciences | Maintains: Buy | $5 → $4 | $4.23 | -5.44% | 7 | Mar 6, 2025 | |
STAA STAAR Surgical Company | Maintains: Buy | $38 → $20 | $18.09 | +10.56% | 9 | Feb 12, 2025 | |
BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $11.73 | +53.45% | 3 | Jan 29, 2025 | |
IRIX IRIDEX | Maintains: Hold | $2 | $0.97 | +106.19% | 2 | May 15, 2024 | |
ALC Alcon | Reiterates: Buy | $95 → $100 | $87.46 | +14.34% | 4 | May 15, 2024 |
Glaukos
May 1, 2025
Maintains: Buy
Price Target: $140 → $115
Current: $93.55
Upside: +22.93%
RxSight
Mar 19, 2025
Maintains: Hold
Price Target: $33 → $28
Current: $15.24
Upside: +83.73%
Sight Sciences
Mar 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $4.23
Upside: -5.44%
STAAR Surgical Company
Feb 12, 2025
Maintains: Buy
Price Target: $38 → $20
Current: $18.09
Upside: +10.56%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $11.73
Upside: +53.45%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $0.97
Upside: +106.19%
Alcon
May 15, 2024
Reiterates: Buy
Price Target: $95 → $100
Current: $87.46
Upside: +14.34%